Author:
Liu Zhe,Wang Qilong,Chi Yang,Chen Rui,Zhao Lichun,Liu Zhihui,Zhai Jianxiu,Li Sikai,Han Na,Yin Jun
Reference56 articles.
1. Cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023
2. Perioperative Systemic Therapy for Resectable Non-Small Cell Lung Cancer;Muthusamy;JNCCN J. Nat. Comprehensive Cancer Network,2022
3. Lung cancer immunotherapy: progress, pitfalls, and promises;Lahiri;Mol. Cancer,2023
4. Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance;Wu;Int. J. Mol. Sci.,2022
5. D.S. Ettinger, D.E. Wood, D.L. Aisner, W. Akerley, J.R. Bauman, A. Bharat, D.S. Bruno, J.Y. Chang, L.R. Chirieac, M. DeCamp, T.J. Dilling, J. Dowell, G.A. Durm, S. Gettinger, T.E. Grotz, M.A. Gubens, A. Hegde, R.P. Lackner, M. Lanuti, J. Lin, B.W. Loo, C.M. Lovly, F. Maldonado, E. Massarelli, D. Morgensztern, T. Ng, G.A. Otterson, S.P. Patel, T. Patil, P.M. Polanco, G.J. Riely, J. Riess, S.E. Schild, T.A. Shapiro, A.P. Singh, J. Stevenson, A. Tam, T. Tanvetyanon, J. Yanagawa, S.C. Yang, E. Yau, K.M. Gregory, M. Hughes, NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023, J Natl Compr Canc Netw 21 (2023). https://doi.org/10.6004/jnccn.2023.0020.